Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03887988 · ClinicalTrials.gov registry record

Orbital Fractures Registry

A clinical trial of Orbital Fractures and Blow Out Fracture of Orbit, sponsored by AO Innovation Translation Center.

Active
Registry status
300
Enrollment target
14
Study locations

NCT03887988: Active study of Orbital Fractures and Blow Out Fracture of Orbit, sponsored by AO Innovation Translation Center.

NCT03887988 is a study of Orbital Fractures and Blow Out Fracture of Orbit that is active but no longer recruiting, run by AO Innovation Translation Center. The registered enrollment target is 300 participants. The trial reports 14 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03887988, a study of Orbital Fractures and Blow Out Fracture of Orbit, is active but no longer recruiting, sponsored by AO Innovation Translation Center.

ACTIVE NOT RECRUITING
Registry status
300 participants
Enrollment target
14
Study locations

Study Summary

Approximately 300 patients presenting orbital blow-out fracture will be enrolled prospectively in this registry. All patients, surgically and nonsurgically treated as per standard (routine) of care will be followed-up (FU) within the registry for a period of 6 months.

Primary Outcome

The degree of diplopia is quantified by measuring the field of single binocular vision, ranging from 0 to 3. 0: no diplopia 1. mild (diplopia appears more than 30 degrees from the primary position) 2. moderate (diplopia appears between 10 and 30 degrees from the primary position) 3. severe (diplopia appears within 10 degrees from the primary position)

Interventions

  • PROCEDURE Primary "early" reconstruction
  • OTHER Nonsurgical
  • PROCEDURE Primary "delayed" reconstruction
  • PROCEDURE Secondary reconstruction

Study Locations (14)

Other

  • Medical Center Hamburg Eppendorf - Hamburg
  • Klinikum der LMU München - Munich
  • Eramus MC - Rotterdam
  • Mayo Hospital - Lahore
  • Hamad Medical Corporation - Doha
  • Emergency Clinical County Hospital of Constanta - Constanța
  • Federal State Budgetary Institution "National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Healthcare of the Russian Federation - Moscow
  • Clinic for Maxillofacial Surgery, University of Belgrade - Belgrade
  • King Edward VIII Hospital - Durban
  • Uppsala University Hospital - Uppsala
  • Universitaetsspital Basel - Basel

California

  • UC Davis - Sacramento

Catalonia

  • Hospital Vall d' Hebron - Barcelona

Madrid

  • 12 de Octubre University Hospital - Madrid

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2019-11-01
Est. Completion 2026-03
AO Innovation Translation Center

18 total trials

What the registry record for NCT03887988 still lists

NCT03887988 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.

The record links to 2 conditions, with Orbital Fractures appearing as the primary indexed condition, and to 4 interventions - of which Primary "early" reconstruction is the first listed.

NCT03887988 lists 14 locations in 4 states (Other, California, Catalonia).

Frequently Asked Questions

What is clinical trial NCT03887988 about?

NCT03887988 is a clinical study titled "Orbital Fractures Registry". Approximately 300 patients presenting orbital blow-out fracture will be enrolled prospectively in this registry. All patients, surgically and nonsurgically treated as per standard (routine) of care will be followed-up (FU) within the registry for a period of 6 months.

What is the current status of trial NCT03887988?

This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2019-11-01. Estimated completion is 2026-03.

What conditions does trial NCT03887988 study?

This clinical trial studies the following conditions: Orbital Fractures, Blow Out Fracture of Orbit.

What interventions are being tested in trial NCT03887988?

The interventions under investigation include: Primary "early" reconstruction (PROCEDURE), Nonsurgical (OTHER), Primary "delayed" reconstruction (PROCEDURE), Secondary reconstruction (PROCEDURE).

Who is sponsoring clinical trial NCT03887988?

This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03887988 being conducted?

This trial has 14 study locations across California, Catalonia, Madrid. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Orbital Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03887988, the US trial registry maintained by the National Library of Medicine. NCT03887988 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.